No Data
PharmaEngine-B (02617): Sun Delong Appointed as Chief Operating Officer
Pharvaris-B (02617) announced that Mr. Sun Delong has been appointed by the company's board of directors as Chief Operating Officer of the company, effective June 12, 2026. In this role, Mr. Sun will be responsible for all aspects of the company’s commercial operations. Mr. Sun brings over twenty years of extensive experience in the biopharmaceutical industry, with comprehensive management expertise spanning from frontline pharmaceutical marketing and medical affairs to full-scale corporate operations.
PharmaEngine-B shares rose after announcing that pivotal Phase II clinical data for tienogotinib monotherapy in advanced biliary tract cancer will be presented at the 2026 ASCO Annual Meeting.
PharmaEngine-B (02617.HK) rose more than 4%. As of the time of writing, it was up 4.05% at HK$32.74, with a trading volume of HK$45.2553 million.
PharmaEngine-B (02617): Announced pivotal Phase II clinical data of tienogotinib monotherapy in advanced biliary tract cancer at the 2026 American Society of Clinical Oncology (ASCO) meeting
Pharnext-B (02617) announced that the company presented the latest research findings on its core product, tienogotinib monotherapy in Chinese patients with advanced biliary tract cancer previously treated with FGFR inhibitors, as a poster presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago.
Top-performing Hong Kong stocks this week | New stock frenzy! DeepIntent Intelligence surged nearly 702% in its debut week; Lenovo Group rose over 52%, fueled by Dell's better-than-expected earnings that sparked a rally across the Lenovo ecosystem; Biren
This week, the Hang Seng Index declined by 1.65% cumulatively, closing at 25,182.39 points; the Hang Seng Tech Index rose by 0.3% over the same period, closing at 4,884.23 points; and the Hang Seng China Enterprises Index fell by 1.46% cumulatively, closing at 8,425.82 points.
Express News | Seven technology stocks, including YOFC, DeepBlue Technology, Convergence Technologies, and Hesai Group, have been added to the Hong Kong Exchange Tech 100 Index.
The Hang Seng Tech Index has added seven stocks, including DeepGlint (01384.HK) and Hesai (02525.HK), and removed China Ruyi (00136.HK), among others.
Hong Kong Exchange (00388.HK) announced the results of the semi-annual review of the Hong Kong Exchanges Technology 100 Index, adding DeepSeek-W (01384.HK), VTC Group (01729.HK), Hesai-W (02525.HK), Geekplus-W (02590.HK), Tegene (02617.HK), Caocao Mobility (02643.HK), and Yangtze Optical Fibre and Cable (06869.HK). Stocks removed from the index include China Ruyi (00136.HK), Travelsky (00696.HK), and Livzon Pharmaceutical (01513.HK).